ANVISA recognises CEPs
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
At the beginning of December, a news in the EDQM website newsroom informed that the Brazilian health authority ANVISA (Agência Nacional de Vigilância Sanitária) has started to recognise evaluation reports and documents from other authorities as part of its assessments. This includes, for example, the CEP of the EDQM, which can now be used when applying for the 'Letter of Suitability of the Active Pharmaceutical Ingredient (CADIFA)' and can therefore provide support when applying for medicinal products in Brazil.
Other authorities whose evaluations are now recognised are listed below:
- European Medicines Agency (EMA)
- Health Canada
- World Health Organisation (WHO)
- Swissmedic
- UK Medicines and Healthcare products Regulatory Agency (MHRA)
- US Food and Drug Administration (FDA)
- Australian Therapeutic Goods Administration (TGA)
Further information can be found in the newsroom on the EDQM website.
Related GMP News
21.10.2026EMA Clarifies ESMP Reporting for Critical Medicine Shortages
20.10.2026EDQM Updates Guidance on CEP Sister File Applications
20.10.2026EDQM Revises Guidance on Electronic Submissions for CEP Applications
14.10.2026Bioassays in the United States Pharmacopoeia - Two Chapters come into Force in Spring
07.10.2026CEP 2.0: EDQM Updates Guidance on the Use of Certificates of Suitability
23.09.2026IRIS Portal: EMA expands digital Procedure Management